Company / FCF Margin
IRONWOOD PHARMACEUTICALS INC FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
42.9%
FY2025
5-year range
41.4% / 66.6%
FY2021-FY2025
Trend
-35.6%
vs FY2024
Sector context
#6 of 133
Health Care
What the data says
Among 133 Health Care companies, IRONWOOD PHARMACEUTICALS INC is in the top 5% for fcf margin. FCF Margin has fluctuated over the past 10 years, ranging from -198.5% in FY2017 to 66.6% in FY2024.
Based on SEC 10-K filings.
42.9% in FY2025 with a 5-year CAGR of +63.4%. Top quartile in the Health Care sector.
Improved from 41.4% to 42.9% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +0.0pp
- 5-Year Change
- +63.4pp
- 10-Year Change
- -
Sector benchmark
Top 5% in Health CareTop 5% of 133This company 42.9% Sector average -632.8%
▼
+106.8% above sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 35.6% year-over-year.
- Currently 675.7pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2024.
- Lowest fcf margin in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 42.9% | -35.6% |
| FY2024 | 66.6% | +61.1% |
| FY2023 | 41.4% | -3.5% |
| FY2022 | 42.9% | -32.2% |
| FY2021 | 63.2% | +407.7% |
| FY2020 | -20.5% | -2575.9% |
| FY2019 | 0.8% | +107.5% |
| FY2018 | -11.0% | +94.5% |
| FY2017 | -198.5% | -1704.6% |
| FY2016 | -11.0% | +85.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026